Overview

Combination Chemotherapy in Treating Women With Stage I Breast Cancer

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which combination chemotherapy regimen is more effective in treating early breast cancer. PURPOSE: Randomized phase III trial to determine the effectiveness of different regimens of combination chemotherapy in treating women who have stage I breast cancer.
Phase:
Phase 3
Details
Lead Sponsor:
UNICANCER
Treatments:
Cyclophosphamide
Epirubicin
Fluorouracil